DTR Staff Publications about Programs

Jett DA.  2016.  The NIH Countermeasures Against Chemical Threats Program: overview and special challenges.  Ann N Y Acad Sci. 1374 (1):5-9. PMID:  27398820. 

Cywin CL, Tamiz AP.  2017.  National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward.  Neurotherapeutics. 14(4):1066-1069. PMID:  28405931. 

Kehne JH, Klein BD, Raeissi S, Sharma S.  2017.  The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP).  Neurochem Res. 42(7):1894-1903. PMID:  28462454. 

Schor NF, Tamiz AP, Koroshetz WJ; NINDS Ultra-Rare Gene-based Therapy (URGenT) Working Group, Broome AM.  2021.  NINDS launches network to develop treatments for ultra-rare neurological diseases.  Nat Biotechnol.  PMID: 34737446. 

Tamiz AP, Koroshetz WJ, Dhruv NT, Jett DA. 2022. A focus on the neural exposome. Neuron. PMID: 35349785.

Was this page helpful?
Form Approved OMB# 0925-0648 Exp. Date 06/2024